| pubmed-article:10533860 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10533860 | lifeskim:mentions | umls-concept:C0376624 | lld:lifeskim |
| pubmed-article:10533860 | lifeskim:mentions | umls-concept:C0012652 | lld:lifeskim |
| pubmed-article:10533860 | lifeskim:mentions | umls-concept:C0032113 | lld:lifeskim |
| pubmed-article:10533860 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:10533860 | pubmed:issue | 9187 | lld:pubmed |
| pubmed-article:10533860 | pubmed:dateCreated | 1999-11-19 | lld:pubmed |
| pubmed-article:10533860 | pubmed:abstractText | The largest number of adult cases of haemolytic uraemic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP) during an Escherichia coli O157 outbreak occurred in 1996 in central Scotland. Adults who develop HUS/TTP induced by E. coli O157 tend to be elderly and have a historical mortality rate of almost 90% when treated conservatively. Therefore the decision was made to treat adults who developed HUS/TTP during this outbreak with therapeutic plasma exchange (TPE). We report our outcome with this controversial treatment. | lld:pubmed |
| pubmed-article:10533860 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10533860 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10533860 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10533860 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10533860 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10533860 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10533860 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:10533860 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:MurphyJJ | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:JonesG AGA | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:ToddW TWT | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:SoutarR LRL | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:HutchinsonS... | lld:pubmed |
| pubmed-article:10533860 | pubmed:author | pubmed-author:DundasSS | lld:pubmed |
| pubmed-article:10533860 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10533860 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:10533860 | pubmed:volume | 354 | lld:pubmed |
| pubmed-article:10533860 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10533860 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10533860 | pubmed:pagination | 1327-30 | lld:pubmed |
| pubmed-article:10533860 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:meshHeading | pubmed-meshheading:10533860... | lld:pubmed |
| pubmed-article:10533860 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10533860 | pubmed:articleTitle | Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak. | lld:pubmed |
| pubmed-article:10533860 | pubmed:affiliation | Department of Infectious Diseases, Monklands Hospital, Lanarkshire, UK. | lld:pubmed |
| pubmed-article:10533860 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10533860 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10533860 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10533860 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10533860 | lld:pubmed |
